{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:24:35Z","timestamp":1791329075820,"version":"4.3.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The authors sought to evaluate visual outcomes in patients with varying etiologies of neovascular glaucoma (NVG), who were treated with glaucoma drainage devices (GDD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective case series of patients at a large academic teaching institution who had surgical intervention for neovascular glaucoma between September 2011 and May 2019. Eyes were included if there was documented neovascularization of the iris\/angle with an intraocular pressure (IOP) &gt;\u200921\u2009mmHg at presentation. Eyes must also have been treated with surgical intervention that included a GDD. Primary outcome measure was visual acuity at the 1-year post-operative visit. Secondary outcome measure was qualified success after surgery defined by: pressure criteria (5\u2009mmHg &lt; IOP\u2009\u2264\u200921\u2009mmHg), no re-operation for elevated IOP, and no loss of LP vision.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One hundred twenty eyes met inclusion criteria. 61.7% had an etiology of proliferative diabetic retinopathy (PDR), 23.3% had retinal vein occlusions (RVO), and the remaining 15.0% suffered from other etiologies. Of patients treated with GDD, eyes with PDR had better vision compared to eyes with RVO at final evaluation (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.041). There was a statistically significant difference (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.027) in the mean number of glaucoma medications with Ahmed eyes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200970) requiring 1.9 medications and Baerveldt eyes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200946) requiring 1.3 medications at final evaluation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In our study, many patients with NVG achieved meaningful vision, as defined by World Health Organization (WHO) guidelines, and IOP control after GDD. Outcomes differed between patients with PDR and RVO in favor of the PDR group. Different GDD devices had similar performance profiles for VA and IOP outcomes. Direct prospective comparison of Baerveldt, Ahmed, and cyclophotocoagulation represents the next phase of discovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-021-02212-x","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T10:02:52Z","timestamp":1639994572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The influence of etiology on surgical outcomes in neovascular glaucoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Charles M.","family":"Medert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Q.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Vanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Richard K.","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Wellik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"issue":"5","key":"2212_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.preteyeres.2007.06.001","volume":"26","author":"SS Hayreh","year":"2007","unstructured":"Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26(5):470\u201385.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"2212_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/IIO.0b013e31821e5960","volume":"51","author":"LC Olmos","year":"2011","unstructured":"Olmos LC, Lee RK. Medical and surgical treatment of neovascular glaucoma. Int Ophthalmol Clin. 2011;51(3):27\u201336.","journal-title":"Int Ophthalmol Clin"},{"key":"2212_CR3","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/S0161-6420(97)30078-5","volume":"104","author":"TE Eid","year":"1997","unstructured":"Eid TE, Katz LJ, Spaeth GL, Augsburger JJ. Tube-shunt surgery versus neodymium: YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmology. 1997;104:1692\u2013700.","journal-title":"Ophthalmology"},{"issue":"5","key":"2212_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/09286586.2020.1755445","volume":"27","author":"PA Lin","year":"2020","unstructured":"Lin PA, Lee CY, Huang FC, Huang JY, Hung JH, Yang SF. Trend of Neovascular Glaucoma in Taiwan: a 15-year Nationwide population-based cohort study. Ophthalmic Epidemiol. 2020;27(5):390\u20138.","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"2212_CR5","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.3390\/healthcare9020144","volume":"9","author":"GBD","year":"2021","unstructured":"GBD. 2019 blindness and vision impairment collaborators; vision loss expert Group of the Global Burden of disease study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet glob. Health. 2021;9(2):e144\u201360.","journal-title":"Health"},{"issue":"1","key":"2212_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/09286586.2020.1792937","volume":"28","author":"HDJ Hogg","year":"2021","unstructured":"Hogg HDJ, Talks JS, Pearce MP, Di Simplicio S. Real-world visual and neovascularisation outcomes from anti-VEGF in central retinal vein occlusion. Ophthalmic Epidemiol. 2021;28(1):70\u20136.","journal-title":"Ophthalmic Epidemiol"},{"issue":"10","key":"2212_CR7","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.7150\/ijms.35267","volume":"16","author":"Z Xie","year":"2019","unstructured":"Xie Z, Liu H, Du M, Zhu M, Tighe S, Chen X, et al. Efficacy of Ahmed Glaucoma valve implantation on Neovascular Glaucoma. Int J Med Sci. 2019;16(10):1371\u20136.","journal-title":"Int J Med Sci"},{"issue":"6","key":"2212_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000095865","volume":"220","author":"Y Kiuchi","year":"2006","unstructured":"Kiuchi Y, Sugimoto R, Nakae K, et al. Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica. 2006;220(6):383\u20138.","journal-title":"Ophthalmologica"},{"issue":"5","key":"2212_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajo.2008.11.015","volume":"147","author":"Y Takihara","year":"2009","unstructured":"Takihara Y, Inatani M, Fukushima M, et al. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol. 2009;147(5):912\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2212_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00417-019-04256-8","volume":"257","author":"Z Shchomak","year":"2019","unstructured":"Shchomak Z, Cordeiro Sousa D, Leal I, Abegao PL. Surgical treatment of neovascular glaucoma: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2019;257(6):1079\u201389.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"2212_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0161-6420(95)30904-9","volume":"102","author":"PA Sidoti","year":"1995","unstructured":"Sidoti PA, Dunphy TR, Baerveldt F, LaBree L, Minckler DS, Lee PP, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology. 1995;102(7):1107\u201318.","journal-title":"Ophthalmology"},{"key":"2212_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/08820530902800801","volume":"24","author":"TA Shazly","year":"2009","unstructured":"Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009;24:113\u201321.","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"2212_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ophtha.2010.07.015","volume":"118","author":"K Barton","year":"2011","unstructured":"Barton K, Gedde SJ, Budenz DL, Feuer WJ, Schiffman J. Ahmed Baerveldt comparison study group. The Ahmed Baerveldt comparison study methodology, baseline patient characteristics, and intraoperative complications. Ophthalmology. 2011;118(3):435\u201342.","journal-title":"Ophthalmology"},{"issue":"2","key":"2212_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ogla.2020.09.010","volume":"4","author":"WS Shalaby","year":"2021","unstructured":"Shalaby WS, Myers JS, Razeghinejad R, et al. Outcomes of valved and nonvalved tube shunts in neovascular glaucoma. Ophthalmol Glaucoma. 2021;4(2):182\u201392.","journal-title":"Ophthalmol Glaucoma"},{"key":"2212_CR15","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s00417-021-05257-2","volume":"259","author":"K Tokumo","year":"2021","unstructured":"Tokumo K, Komatasu K, Yuasa Y, Murakami Y, et al. Treatment outcomes in the neovascular glaucoma tube versus trabeculectomy study. Graefes Arch Clin Ecp Ophthalmol. 2021;259:3067\u201376.","journal-title":"Graefes Arch Clin Ecp Ophthalmol"},{"issue":"8","key":"2212_CR16","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3760\/cma.j.issn.0366-6999.20132654","volume":"127","author":"Z Li","year":"2014","unstructured":"Li Z, Zhou M, Wang W, Huang W, et al. A prospective comparative study on neovascular glaucoma and non-neovascular refractory glaucoma following Ahmed glaucoma valve implantation. Chin Med J. 2014;127(8):1417\u201322.","journal-title":"Chin Med J"},{"issue":"11","key":"2212_CR17","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2147\/OPTH.S151200","volume":"14","author":"Y Shinohara","year":"2017","unstructured":"Shinohara Y, Akiyama H, Magori M, Kishi S. Short-term outcomes after EX-PRESS implantation versus trabeculectomy alone in patients with neovascular glaucoma. Clin Ophthalmol. 2017;14(11):2207\u201313.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"2212_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0161-6420(96)30700-8","volume":"103","author":"RP Mills","year":"1996","unstructured":"Mills RP, Reynolds A, Emond MJ, Barlow WE, Leen MM. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology. 1996;103(2):299\u2013305.","journal-title":"Ophthalmology"},{"key":"2212_CR19","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.ophtha.2016.06.035","volume":"123","author":"PG Christakis","year":"2016","unstructured":"Christakis PG, Kalenak JW, Tsai JC, Zurakowski D, et al. The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology. 2016;123:2093\u2013102.","journal-title":"Ophthalmology"},{"issue":"2","key":"2212_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2014.08.043","volume":"122","author":"DL Budenz","year":"2015","unstructured":"Budenz DL, Barton K, Gedde SJ, Feuer WJ, et al. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2015;122(2):308\u201316.","journal-title":"Ophthalmology"},{"key":"2212_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajo.2017.01.003","volume":"176","author":"PG Christakis","year":"2017","unstructured":"Christakis PG, Zhang D, Budenz DL, Barton K, et al. Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study. Am J Ophthalmol. 2017;176:118\u201326.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2212_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajo.2005.03.031","volume":"140","author":"SJ Gedde","year":"2005","unstructured":"Gedde SJ, Schiffman JC, Geuer WJ, Parrish RK 2nd, et al. The tube versus trabeculectomy study: design and baseline characteristics of study paitents. Am J Ophthalmol. 2005;140(2):275\u201387.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2212_CR23","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.3390\/healthcare9020130","volume":"9","author":"GBD","year":"2021","unstructured":"GBD. 2019 blindness and vision impairment collaborators; vision loss Exper Group of the Global Burden of disease study. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study. Lancet blob. Health. 2021;9(2):e130\u201343.","journal-title":"Health"},{"issue":"16","key":"2212_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12886-016-0265-6","volume":"8","author":"S Wang","year":"2016","unstructured":"Wang S, Gao X, Qian N. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta analysis. BMC Ophthalmol. 2016 Jun;8(16):83.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"2212_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ophtha.2010.07.016","volume":"118","author":"DL Budenz","year":"2011","unstructured":"Budenz DL, Barton K, Feuer WJ, Schiffman J, et al. Treatment outcomes in the Ahmed Baerveldt comparison study after 1 year follow -up. Ophthalmology. 2011;118(3):443\u201352.","journal-title":"Ophthalmology"},{"issue":"1","key":"2212_CR26","first-page":"15637","volume":"10","author":"A Ricca","year":"2020","unstructured":"Ricca A, Boone K, Boldt HV, Gehrs KM, Russell SR, et al. Attaining functional levels of visual acuity after vitrectomy for retinal detachment secondary to proliferative diabetic retinopathy. Sci Tep. 2020;10(1):15637.","journal-title":"Sci Tep"},{"issue":"2","key":"2212_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/IAE.0000000000000310","volume":"35","author":"E Rahimy","year":"2015","unstructured":"Rahimy E, Pitcher JD 3rd, Gee CJ, Kreiger AE, et al. Diabetic tractional retinal detachment repair by vitreoretinal fellows in a county health system. Retina. 2015;35(2):303\u20139.","journal-title":"Retina"},{"key":"2212_CR28","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0161-6420(01)00775-8","volume":"108","author":"JA Sivak-Callcott","year":"2001","unstructured":"Sivak-Callcott JA, O\u2019Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108:1767\u201376.","journal-title":"Ophthalmology"},{"issue":"6","key":"2212_CR29","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.ajo.2010.01.008","volume":"149","author":"Y Saito","year":"2010","unstructured":"Saito Y, Higashide T, Takeda H, Murotani E, et al. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Am J Ophthalmol. 2010;149(6):964\u201372.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2212_CR30","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1177\/112067210901900620","volume":"19","author":"S Ciftci","year":"2009","unstructured":"Ciftci S, Sakalar YB, Unlu K, Keklikci U, et al. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma. Eur J Ophthalmol. 2009;19(6):1028\u201333.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"2212_CR31","first-page":"A5229","volume":"63","author":"A Rasul","year":"2016","unstructured":"Rasul A, Subhi Y, S\u00f8rensen TL, Munch IC. Non-physician delivered intravitreal injection service is feasible and safe - a systematic review. Dan Med J. 2016;63(5):A5229.","journal-title":"Dan Med J"},{"issue":"8","key":"2212_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2014.01.036","volume":"121","author":"K Barton","year":"2014","unstructured":"Barton K, Feuer WJ, Budenz DL, et al. Three-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2014;121(8):1547\u20131557.e1.","journal-title":"Ophthalmology"},{"issue":"3","key":"2212_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00061198-200406000-00011","volume":"13","author":"FE Lima","year":"2004","unstructured":"Lima FE, Magacho L, Carvalho DM, Susanna R, Avila MP. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma. 2004;13(3):233\u20137.","journal-title":"J Glaucoma"},{"issue":"3","key":"2212_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/IJG.0b013e31817d235c","volume":"18","author":"N Yildirim","year":"2009","unstructured":"Yildirim N, Yalvac IS, Sahin A, Ozer A, Bozca T. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. J Glaucoma. 2009;18(3):192\u20136.","journal-title":"J Glaucoma"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02212-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02212-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02212-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T15:59:39Z","timestamp":1726329579000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02212-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2212"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02212-x","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"23 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) at the University of Miami School of Medicine approved this protocol before beginning the study and it followed the tenets of the Declaration of Helsinki. A waiver of informed consent was granted by the IRB for this retrospective observational study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"440"}}